Related references
Note: Only part of the references are listed.Characteristics of Reported Industry Payments to Neurosurgeons: A 5-Year Open Payments Database Study
Aladine A. Elsamadicy et al.
WORLD NEUROSURGERY (2021)
Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology
Aaron P. Mitchell et al.
ONCOLOGIST (2019)
Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019
Stacie B. Dusetzina et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Trends in financial relationships between industry and individual medical oncologists in the United States from 2014 to 2017: A cohort study.
Deborah Catherine Marshall et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Investigating the Gender Pay Gap in Industry Contributions to Academic Neurosurgeons
Ledibabari M. Ngaage et al.
WORLD NEUROSURGERY (2019)
Scope and nature of financial conflicts of interest between neurologists and industry 2013-2016
Nathaniel M. Robbins et al.
NEUROLOGY (2019)
Association between physician characteristics and payments from industry in 2015-2017: observational study
Kosuke Inoue et al.
BMJ OPEN (2019)
Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act
Christopher Scott Brunt
HEALTH SERVICES RESEARCH (2019)
Impact of Industry Payments on Prescribing Patterns for Tumor Necrosis Factor Inhibitors Among Medicare Beneficiaries
Partik Singh et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2019)
Industry Payments to Physicians and Prescriptions of Brand-Name Proton-Pump Inhibitors
Elliot Morse et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2019)
Association between conflict of interest and published position on tumor-treating fields for the treatment of glioblastoma
Michael J. Hayes et al.
JOURNAL OF CANCER POLICY (2019)
Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists
Julius K. Weng et al.
JAMA NETWORK OPEN (2019)
The Receipt of Industry Payments is Associated With Prescribing Promoted Alpha-blockers and Overactive Bladder Medications
Parth K. Modi et al.
UROLOGY (2018)
Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015
Kathryn R. Tringale et al.
JAMA INTERNAL MEDICINE (2018)
Pharmaceutical Industry Payments and Oncologists' Selection of Targeted Cancer Therapies in Medicare Beneficiaries
Aaron P. Mitchell et al.
JAMA INTERNAL MEDICINE (2018)
Assessing the domino effect: Female physician industry payments fall short, parallel gender inequalities in medicine
Anna Weiss et al.
AMERICAN JOURNAL OF SURGERY (2018)
Types and Distribution of Payments From Industry to Physicians in 2015
Kathryn R. Tringale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
US drug marketing: how does promotion correspond with health value?
Tyler Greenway et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
US drug marketing: how does promotion correspond with health value?
Tyler Greenway et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Association between physicians' interaction with pharmaceutical companies and their clinical practices: A systematic review and meta-analysis
Hneine Brax et al.
PLOS ONE (2017)
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014
Deborah C. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Disclosure of Industry Payments to Physicians: An Epidemiologic Analysis of Early Data From the Open Payments Program
Deborah C. Marshall et al.
MAYO CLINIC PROCEEDINGS (2016)
The Physician Payments Sunshine Act - Two Years of the Open Payments Program
Shantanu Agrawal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts
James S. Yeh et al.
JAMA INTERNAL MEDICINE (2016)
Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries
Colette DeJong et al.
JAMA INTERNAL MEDICINE (2016)
Distribution and Patterns of Industry-Related Payments to Oncologists in 2014
Deborah C. Marshall et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Financial Relationships With Industry Among National Comprehensive Cancer Network Guideline Authors
Aaron P. Mitchell et al.
JAMA ONCOLOGY (2016)
Drug Pricing Trends for Orally Administered Anticancer Medications Reimbursed by Commercial Health Plans, 2000-2014
Stacie B. Dusetzina
JAMA ONCOLOGY (2016)
Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
Roy H. Perlis et al.
PLOS ONE (2016)
Orthopaedic Surgeons Receive the Most Industry Payments to Physicians but Large Disparities are Seen in Sunshine Act Data
Andre M. Samuel et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2015)
The prevalence and influence of self-reported conflicts of interest by editorial authors of phase III cancer trials
Tatiana Goberstein Lerner et al.
CONTEMPORARY CLINICAL TRIALS (2012)
Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
Geoffrey K. Spurling et al.
PLOS MEDICINE (2010)
Share Paper
